Phase4 Partners Limited

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Phase4 Partners Limited
CRD #161591
SEC #802-75267
CIK #0001600023
AUM
Employees
Phone443330237313
Address1 Cavendish Place
London, United Kingdom
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($)
1.00.80.60.40.20.02009201420192025
Type Form D Funds Date Sold AUM
VC Phase4 Ventures III LP 2012-03-29 11.7 M
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
EDGAR Form CIK 2011 - 2026
3 [0001600023]
4 [0001600023]
SC 13D [0001600023]
SC 13G [0001600023]
Form 13D/13G Filer Form 13D/13G Subject Filed
Phase4 Partners Ltd Albireo Pharma Inc [2016-11-14]
Phase4 Partners Ltd Nabriva Therapeutics AG [2016-02-12]
Phase4 Partners Ltd OncoMed Pharmaceuticals Inc [2014-02-13]
Form 3/4/5 Subject 2011 - 2026
Albireo Pharma Inc
Phase4 Ventures III General Partner Ltd
Phase4 Partners Ltd
Phase4 Ventures III LP
Phase4 Ventures III GP LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Albireo Pharma Inc ALBO
Common Stock
2018-01-30 Sell 98,500 $34.40 3,388,400
Albireo Pharma Inc ALBO
Common Stock
2018-01-30 Sell 1,500 $37.06 55,590
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com